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Abstract
The Wnt and Notch signalling pathways play major roles in
mammary gland development and tumourigenesis. During develop-
ment, these pathways have opposing effects. However, in a recent
paper Ayyanan and coworkers show that expression of Wnt1 is
sufficient to transform primary human mammary epithelial cells, and
that this is in part due to activation of the Notch pathway. This
indicates that during tumourigenesis the two pathways cooperate.
Here we ask why activation of Wnt signalling alone is sufficient to
cause transformation; whether there is evidence for inhibitory
crosstalk between the pathways during tumourigenesis; and
whether cooperation between these pathways occurs in other
forms of cancer.
Through retroviral expression of Wnt1, Ayyannan and co-
workers were able to demonstrate that a subset of primary
human mammary epithelial cells (HMECs) display increased
proliferation, an ability to form multicellular spheres and a
failure to senesce following exposure to Wnt1 for a period of
several weeks [1]. Furthermore, these cells formed tumours
when they were injected into immunocompromised mice. This
is rather unusual because expression of more than one
oncogene is normally required to transform epithelial cells.
For example, human embryonic kidney cells cannot be
transformed by expression of hTERT (the catalytic subunit of
telomerase), SV40 large T antigen, or H-ras alone [2]. In fact,
it requires the expression of all three because several
different cellular properties must be derailed at once,
including cell proliferation, apoptosis, senescence, adhesion,
polarity and growth. 
Consequently, we ask is there evidence that Wnt signalling
can regulate all of these cellular properties simultaneously?
Wnt signalling is known to affect cell proliferation and growth
in colorectal cancer by stimulating expression of CyclinD1
and  c-myc, respectively [3]. Ayyannan and coworkers also
provide evidence that telomerase activity was activated, as
telomere length was maintained preventing senescence, and
that the p16/Rb and p53 checkpoints were disrupted
affecting the control of both proliferation and apoptosis [1]. In
the latter case, this evidence stems from biochemical data
showing that Wnt1 expression in HMECs elicits a DNA
damage response. In normal cells, this would cause cell
arrest at the p16/Rb or p53 checkpoint. The continued
proliferation of Wnt1-expressing HMECs, despite high levels
of p53, indicates that these checkpoints have been
inactivated or that cells with a nonfunctional form of p53 have
been selected. This can also explain the observed abnormal
karyotypes. However, Wnt/β-catenin signalling can stimulate
chromosomal instability in its own right in colorectal cell lines
[4]. In addition to these effects, local Wnt signalling may
regulate apical-basal cell polarity by depleting Lethal giant
larvae and, hence, promoting the accumulation of the apical
partioning-defective 3/partitioning-defective 6/atypical protein
kinase C complex within a specific region of the cell [5]. In
contrast, global Wnt signalling will deplete Lethal giant larvae
within the whole cell, preventing polarization. Therefore,
constitutive Wnt signalling may contribute to the disruption of
apical-basal cell polarity seen during the transition from
hyperplastic lesions to benign disease [6].
Lastly, Wnt signalling stimulates the self-renewal of many
different adult stem cell populations [7]. Therefore, the
expression of Wnt1 in HMECs may increase the number of
stem cells within this cell population; interestingly, stem cells
exhibit resistance to apoptosis and failure to senesce similar
to those in transformed cells. The increased number of cells
expressing stem/progenitor cell markers in tumours from
mouse mammary tumour virus-Wnt1 mice suggests that this
is likely [8]. Furthermore, given the possible role of cancer
stem cells in tumour development, this regulation of stem cell
self-renewal may contribute significantly to the Wnt1-
mediated transformation of HMECs. Altogether, it is clear that
Wnt signalling regulates many cellular properties at once,
unlike classical oncogenes, which may explain its ability to
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transform HMECs alone. This also illustrates how develop-
mental signalling pathways can deregulate cell behaviour
during the early stages of cancer.
Ayyanan and coworkers [1] also demonstrated that expression
of Wnt1 in HMECs led to subsequent activation of Notch
signalling. Furthermore, studies of a panel of 34 breast
carcinomas showed concomitant upregulation of the Wnt
target genes Lef1 and  Axin2 along with Delta-like 3 and
Delta-like 4, suggesting that the same process takes place in
tumours. Expression of function-blocking Notch ligands
abrogated HMEC transformation by Wnt1, demonstrating
that there is a need for Notch signalling. However, activation
of Notch signalling alone was not sufficient to cause
transformation. What, then, is the role of Notch signalling in
Wnt-mediated trasformation? One possibility is the
upregulation of the transcriptional repressor Slug [9], which
can both stimulate an epithelial to mesenchymal transition,
and prevent PUMA expression, a pro-apoptotic member of
the Bcl-2 family, in response to p53 activation [10] In fact,
Notch signalling has been shown to regulate apoptosis
through many different mechanisms, including inhibition of
p53 [11], which probably reflects regulation of key survival
pathways within cells such as the Akt pathway. Notch
signalling can also stimulate cell proliferation in the rat kidney
cell line RKE by increasing cyclinD1 expression [12], and it
may affect cell growth through regulation of c-myc expression
[13]. Finally, like the Wnt pathway, Notch signalling has been
shown to stimulate the self renewal of stem cells, including
HMECs [14,15].
Since Notch signalling can regulate many of the same cellular
properties as the Wnt pathway, this raises the question of
why is Notch signalling alone insufficient to cause HMEC
transformation? One possibility is a failure to activate
telomerase activity, which thus far is not known to be affected
by Notch signalling. An alternative is expression of the cyclin-
dependent kinase inhibitor p21, preventing cell proliferation,
which has been shown to be a direct target of the pathway in
keratinocytes [16] and is activated in the normal breast
epithelial cell line MCF 10A in response to Notch signalling
(Stylianou S, Brennan K, unpublished data). Interestingly, p21
levels do not rise in HMECs following Wnt1 expression, even
though Notch signalling is activated. One possibility is the
induction of c-Myc expression by Wnt signalling, which in
turn downregulates p21 expression [17]. Alternatively it may
reflect modulation of Notch signalling by the Wnt pathway.
Inhibitory crosstalk has been well documented in these
pathways between Dishevelled and Notch, Notch and
β-catenin, and glycogen synthase kinase-3β and Notch
[18,19]. Furthermore, inhibitory crosstalk between the
pathways has been reported in mammary gland cells. The
pathways have opposing effects on the morphogenesis of the
TAC2 mouse MEC cell line; Wnt signalling promotes
branching of the epithelial ducts formed by TAC2 cells,
whereas activation of the Notch pathway blocks this
morphological differentiation [20]. However, when both
pathways are activated concomitantly, the TAC2 cells still
form branched ducts, indicating that Wnt signalling, in this
instance, can modulate Notch signalling.
Finally, are there other instances in which Wnt and Notch
signalling are closely linked during tumour development? In
fact, examples can be found in tissues derived from all three
germ layers. Within the colon, the two pathways tightly
control the development and maintenance of the colonic
epithelium [15]. Activation of the two pathways together
promotes stem cell renewal, whereas activation of Wnt and
Notch signalling separately promotes differentiation into
secretory cells and enterocytes, respectively. Furthermore,
the same activation of the Notch pathways in response to
Wnt signalling is seen in colorectal tumours [21]. However, it
is not currently clear whether Notch signalling is required for
Wnt-mediated transformation of the colonic epithelium.
Similarly, signalling through both pathways is required for the
maintenance of haematopoietic stem cells and, again,
increased Wnt signalling leads to activation of the Notch
pathway [22]. Furthermore, both pathways are dysregulated
in leukaemia [23], although there has been little study of
whether crosstalk occurs between the two pathways.
Wnt and Notch signals do not always cooperate in tumour
formation. Within the skin, both pathways are again involved
in stem cell regulation and differentiation. However, they have
opposing effects, with Notch signalling promoting
differentiation and Wnt signalling promoting stem cell self
renewal and proliferation [24]. Furthermore, Notch1 has been
shown to act as a tumour suppressor gene in the epidermis
[25], whereas Wnt signalling is clearly oncogenic [7,26].
To conclude, it is now clear that signalling pathways such as
the Wnt and Notch pathways, which regulate development
and tissue maintenance in the adult, control cell fate
decisions by manipulating cell proliferation, death, polarity,
senescence and adhesion, as well as the expression of cell
type specific proteins and transcription factors. Conse-
quently, it is not surprising that these pathways play a
profound role in cancer. In addition, misregulation of these
pathways is often associated with early stages of
tumourigenesis. Finally, it is clear that the Wnt and Notch
pathways are intimately intertwined in both stem cell self-
renewal and cancer.
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